To include your compound in the COVID-19 Resource Center, submit it here.

Gilead starts Phase II lung cancer study of NX 211

GILD began U.S. Phase II testing

Read the full 64 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE